Notably, radiation has been shown to enhance NAT10-mediated acetylation of MORC2 in breast cancer, suggesting that NAT10 may serve as a potential therapeutic target to overcome RT resistance [35]. The gene discussed is NAT10; the disease is breast carcinoma.